EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Clinical Profile of Patients With Hepatocellular Carcinoma Referred for Transarterial Chemoembolization at a Tertiary Center

Beatriz Piaulino de Araujo, João Guilherme Oliveira Vaz, Ana Paula Nunes Bento, Maria Stella Vasconcelos Sales Valente, Juan Mariano Huertas Aguilar, Gabriel Marchetto, Lara Garcia Victório Pessotto, Paolla Ravida Alves de Macedo, Carla Batista Moisés, Fernanda Dias Teramoto, Alexandre Foratto, Aline Garcia und 4 weitere

Transplantation Proceedings · 2026

DOI: 10.1016/j.transproceed.2026.03.003 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Transplantation Proceedings, 2026. Verfasst von Beatriz Piaulino de Araujo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medical Sciences, University of Campinas (UNICAMP), São Paulo, Brazil. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Chemoembolization, Therapeutic. Die Arbeit nennt 11 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hepatocellular carcinoma (HCC) is the most common primary liver cancer and a leading cause of cancer-related mortality worldwide. It is strongly associated with chronic liver diseases such as viral hepatitis, alcohol-related liver disease, and nonalcoholic steatohepatitis. Transarterial chemoembolization (TACE) is indicated for intermediate-stage HCC and may be used for downstaging, bridging to liver transplantation, or palliative treatment. METHODS: This cross-sectional observational study evaluated patients with HCC referred for TACE at the University Hospital of Campinas between 2022 and 2023, who underwent the procedure until 2024. Demographic data, liver disease etiology, laboratory findings, tumor staging (Child-Pugh, BCLC, and MELD), transplant listing status, alpha-fetoprotein (AFP) levels, and tumor characteristics were analyzed. RESULTS: A total of 158 patients were included, with a mean age of 64 years and male predominance (77.85%). Hepatitis C virus infection was the most frequent etiology (31%), followed by alcohol-related liver disease (20.9%) and combined HCV and alcohol use (17%). TACE was performed in 100 patients, mainly for downstaging (37.3%) and prevention of transplant waiting-list dropout (32.3%). Half of the patients presented with a single tumor nodule, with a mean lesion size of 3.8 cm. The mean MELD score was 12.5 and AFP levels showed wide variability. CONCLUSION: The study population demonstrated an epidemiological profile consistent with the literature. TACE was widely used as an effective strategy for tumor control in liver transplant candidates, highlighting its importance in the management of HCC in the Brazilian clinical setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsChemoembolization, TherapeuticHumansMaleFemaleMiddle AgedCross-Sectional StudiesTertiary Care CentersAgedLiver TransplantationAdultNeoplasm StagingTreatment Outcome

Autor:innen und Institutionen

  • Faculty of Medical Sciences, University of Campinas (UNICAMP), São Paulo, Brazil.
  • Department of Surgery, University Hospital, University of Campinas (UNICAMP), São Paulo, Brazil.
  • Department of Surgery, University Hospital, University of Campinas (UNICAMP), São Paulo, Brazil. Electronic address: simoneperales@gmail.com.

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

de Araujo, B. P., Vaz, J. G. O., Bento, A. P. N., Valente, M. S. V. S., Aguilar, J. M. H., Marchetto, G., Pessotto, L. G. V., de Macedo, P. R. A., Moisés, C. B., Teramoto, F. D., Foratto, A., Garcia, A., Meneses, C. J., Boin, I. F. S. F., Perales, S. R., & de Ataíde, E. C. (2026). Clinical Profile of Patients With Hepatocellular Carcinoma Referred for Transarterial Chemoembolization at a Tertiary Center. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2026.03.003

Vancouver

de Araujo BP, Vaz JGO, Bento APN, Valente MSVS, Aguilar JMH, Marchetto G, et al. Clinical Profile of Patients With Hepatocellular Carcinoma Referred for Transarterial Chemoembolization at a Tertiary Center. Transplantation Proceedings. 2026. doi:10.1016/j.transproceed.2026.03.003

BibTeX
@article{deAraujo2026,
  author = {de Araujo, Beatriz Piaulino and Vaz, João Guilherme Oliveira and Bento, Ana Paula Nunes and Valente, Maria Stella Vasconcelos Sales and Aguilar, Juan Mariano Huertas and Marchetto, Gabriel and Pessotto, Lara Garcia Victório and de Macedo, Paolla Ravida Alves and Moisés, Carla Batista and Teramoto, Fernanda Dias and Foratto, Alexandre and Garcia, Aline and Meneses, Cristhian Jaillita and Boin, Ilka de Fatima Santana Ferreira and Perales, Simone Reges and de Ataíde, Elaine Cristina},
  title = {Clinical Profile of Patients With Hepatocellular Carcinoma Referred for Transarterial Chemoembolization at a Tertiary Center},
  journal = {Transplantation Proceedings},
  year = {2026},
  doi = {10.1016/j.transproceed.2026.03.003}
}
Kostenlos starten →